CellenGene Selected for National New Drug Development Project, Advances CAR-T Therapy for Ovarian Cancer
CellenGene, a biotechnology company specializing in cell gene therapy (CEO: Ahn Jae-hyun), has been selected for the 'New Drug Ecosystem ...
KoreaTechDesk | Korean Startup and Technology News
CellenGene, a biotechnology company specializing in cell gene therapy (CEO: Ahn Jae-hyun), has been selected for the 'New Drug Ecosystem ...